Division of HIV/AIDS

Active Projects: 47

Project Investigator
All Organizations Start date End date
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey Susan C. Coffey, MD Division of HIV/AIDS, AIDS Research Institute
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Programming Long Term Durable HIV-1 Specific T cell Responses Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Enhancing Control of HIV by Inhibiting TRAIL Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH Division of HIV/AIDS
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence Monica Gandhi, MD, MPH Division of HIV/AIDS
Family Services Network - Ryan White HIV/AIDS Program Monica Gandhi, MD, MPH Division of HIV/AIDS
IeDEA Consortium East Africa data center Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT-R) Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Work Order for CNICS Admin Core 5 Years (related to NIH R24 A1067039) Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Center for AIDS Research (CFAR), Division of HIV/AIDS, AIDS Research Institute
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV, Hahn K24 Judith A. Hahn, PhD, MD Global Health Sciences Faculty Affiliate, Department of Epidemiology and Biostatistics, Division of HIV/AIDS
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal Judith A. Hahn, PhD, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients Hiroyu Hatano, MD, MHS Division of HIV/AIDS
SFBay CTU Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Sustainable East Africa Research in Community Health Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
ACTG, AIDS Clinical Trial Research Group Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden Diane V. Havlir, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Training in HIV Translational Research Diane V. Havlir, MD Global Health Sciences Faculty Affiliate, Center for AIDS Research (CFAR), Division of HIV/AIDS, AIDS Research Institute
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study Laurence Huang, MD Division of HIV/AIDS, AIDS Research Institute
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes Laurence Huang, MD Division of HIV/AIDS
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Laurence Huang, MD Division of HIV/AIDS, AIDS Research Institute
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases Laurence Huang, MD Division of HIV/AIDS, AIDS Research Institute
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Determinants of Functional Immune Defects in Treated HIV Infection and Aging Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations Vivek Jain, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne F. Luetkemeyer, MD Division of HIV/AIDS
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne F. Luetkemeyer, MD Division of HIV/AIDS
Changing Health through Food Support (CHeFS) Program- Expanded Program Sheri D. Weiser, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, Prevention Science (formerly the Center for AIDS Prevention Studies or CAPS)
Mechanisms and longitudinal effects of HIV-related stigma on women's adherence and outcomes Sheri D. Weiser, MD Division of HIV/AIDS, AIDS Research Institute
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV, WEISER CONTINUTATION Sheri D. Weiser, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Center of Excellence Division of HIV/AIDS
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Division of HIV/AIDS
Mentoring patient-oriented research on the health consequences of polydrug use Elise Riley, PhD Division of HIV/AIDS, AIDS Research Institute
Effects of Polydrug Use, Adulterants and HIV on Cardiac Injury in Homeless Women Elise Riley, PhD Division of HIV/AIDS
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling Sulggi A. Lee, MD Division of HIV/AIDS, AIDS Research Institute
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Identifying barriers to diabetes and HIV co-management in vulnerable populations Kartika Palar, PhD Division of HIV/AIDS, AIDS Research Institute
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
UCSF- Kenyan radiology residency training William P. Dillon, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, Department of Radiology and Biomedical Imaging
Antimalarial drugs in Ugandan populations Melissa Conrad, PhD Division of HIV/AIDS
Reducing dietary risks associated with noncommunicable disease Lynn Silver, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS

Archived Projects: 273

Project Investigator
All Organizations Start date End date
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 Henry Chambers, MD Division of HIV/AIDS
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, Curry International Tuberculosis Center
Innovative incentive strategies for sustainable HIV testing and linkage to care Gabriel Chamie, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Optimizing Rapid and Full Engagement in Care for Persons with Newly Diagnosed HIV Katerina Christopoulos, MD, MPH Division of HIV/AIDS
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients Steven G. Deeks, MD Division of HIV/AIDS
HIV Controllers: A Potential Model for HIV Eradication Steven G. Deeks, MD Division of HIV/AIDS
Innate Effector Function and HIV-1 Control Steven G. Deeks, MD Division of HIV/AIDS
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients Steven G. Deeks, MD Division of HIV/AIDS
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT Steven G. Deeks, MD Division of HIV/AIDS
Epigenetic Regulation of HIV Latency Steven G. Deeks, MD Division of HIV/AIDS
HIV Entry Inhibitors: A New Therapeutic Option Steven G. Deeks, MD Division of HIV/AIDS
Atripla Adherence and Resistance Relationships [I] Steven G. Deeks, MD Division of HIV/AIDS
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation Steven G. Deeks, MD Division of HIV/AIDS
Elite Controllers Steven G. Deeks, MD Division of HIV/AIDS
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven G. Deeks, MD Division of HIV/AIDS
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven G. Deeks, MD Division of HIV/AIDS
San Francisco National Clinical Trial Center, ESPIRIT Steven G. Deeks, MD Division of HIV/AIDS
Atripla Adherence and Resistance Relationships [II] Steven G. Deeks, MD Division of HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response Steven G. Deeks, MD Division of HIV/AIDS
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven G. Deeks, MD Center for AIDS Research (CFAR), Division of HIV/AIDS, AIDS Research Institute
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven G. Deeks, MD Division of HIV/AIDS
UCSF/Ragon Collaboration on HIV "Elite" Controllers Steven G. Deeks, MD Division of HIV/AIDS
Impact of HIV-Associated Inflammation on Disease Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven G. Deeks, MD Division of HIV/AIDS
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven G. Deeks, MD Division of HIV/AIDS
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir Steven G. Deeks, MD Division of HIV/AIDS
Core B: Specimen Repository Core Steven G. Deeks, MD Division of HIV/AIDS
EraMune Project Steven G. Deeks, MD Division of HIV/AIDS
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir Steven G. Deeks, MD Division of HIV/AIDS
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research Steven G. Deeks, MD Division of HIV/AIDS
Task Order: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven G. Deeks, MD Division of HIV/AIDS
Characterizing the Role of Immune Activation in HIV Persistence Steven G. Deeks, MD Division of HIV/AIDS
HIV Specific T-Cell Responses in Rectal Mucosa Steven G. Deeks, MD Division of HIV/AIDS
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven G. Deeks, MD Division of HIV/AIDS
T Regulatory Cells and T Cell Activation in HIV Disease Steven G. Deeks, MD Division of HIV/AIDS
Treating HIV-infected Elite Controllers as a Model of HIV Remission Steven G. Deeks, MD Division of HIV/AIDS
Treatment Intensification for Drug-Resistant HIV Steven G. Deeks, MD Division of HIV/AIDS
Deeks Order CNICS: June 2014-Aug 2016 Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Identifying and Targeting HIV Persistence in T Cell Subsets during ART Steven G. Deeks, MD Division of HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven G. Deeks, MD Division of HIV/AIDS
Identifying and targeting HIV persistence in T Cell subsets during ART Steven G. Deeks, MD Division of HIV/AIDS
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven G. Deeks, MD Division of HIV/AIDS
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda Matthew G. Dorsey, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response Monica Gandhi, MD, MPH Division of HIV/AIDS
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH Division of HIV/AIDS
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trials Group Monica Gandhi, MD, MPH Division of HIV/AIDS, AIDS Research Institute
Hair measures to assess adherence and explain outcomes in an HIV clinical trial Monica Gandhi, MD, MPH Division of HIV/AIDS
Developing a Mentoring Network of Diverse Mental Health Professionals Utilizing the CNICS Platform Monica Gandhi, MD, MPH Division of HIV/AIDS
Positive Health Access to Services and Treatment (PHAST) Monica Gandhi, MD, MPH Division of HIV/AIDS
R24 for the CFAR-Network for the Integrated Clinical Science, CNICS Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Center for AIDS Research (CFAR), Division of HIV/AIDS, AIDS Research Institute
Differentiated care for improved health systems efficiency and health outcomes in Zambia (Efficient Health) Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Geng Work Order CNICS: Crane R56 MI Packets Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Evaluation of Haiti Quality Improvement of HIV Care Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Better Information for Health in Zambia Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
CFAR Network (CNICS) Research Platform: Channeling Bias Study Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Evaluation of Haiti Quality Improvement of HIV Care Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Health Qual Impact Evaluation (HQIE) Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Virologic and Host Factors Contributing to HIV Control in Elite Controllers Hiroyu Hatano, MD, MHS Division of HIV/AIDS
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study Hiroyu Hatano, MD, MHS Division of HIV/AIDS, AIDS Research Institute
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Feasibility of a Point-Of-Care CD4+ Test Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane V. Havlir, MD Division of HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane V. Havlir, MD Division of HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) Diane V. Havlir, MD Division of HIV/AIDS
Task Order # 7: Supplement to SSS A5254 Diane V. Havlir, MD Division of HIV/AIDS
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trials Group; Protocol Funds Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane V. Havlir, MD Division of HIV/AIDS
AIDS Research and Services at SFGH Diane V. Havlir, MD Division of HIV/AIDS
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane V. Havlir, MD Division of HIV/AIDS
Task Order # 9: Supplement to SSS A5272 Diane V. Havlir, MD Division of HIV/AIDS
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Diane V. Havlir, MD Division of HIV/AIDS
UCSF HIV/AIDS Management Training Programs Diane V. Havlir, MD Division of HIV/AIDS
UCSF HIV Clinical Trials Unit Diane V. Havlir, MD Division of HIV/AIDS
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Diane V. Havlir, MD Division of HIV/AIDS
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Diane V. Havlir, MD Division of HIV/AIDS
International AIDS Research and Prevention Diane V. Havlir, MD Division of HIV/AIDS
Reducing Failure-to-Initiate ART: Streamlined ART Start Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) Diane V. Havlir, MD Division of HIV/AIDS
Task Order # 6: Supplement to SSS A5257 Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Neurological AIDS Research Consortium Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Diane V. Havlir, MD Division of HIV/AIDS
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Diane V. Havlir, MD Division of HIV/AIDS
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) Diane V. Havlir, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Training in HIV Primary Care - Uganda Clinicians Diane V. Havlir, MD Division of HIV/AIDS
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Diane V. Havlir, MD Division of HIV/AIDS
Task Order Agreement No. CRB-DCR01-S-09-00325 Diane V. Havlir, MD Division of HIV/AIDS
Task Order Supplement to A5267 Diane V. Havlir, MD Division of HIV/AIDS
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane V. Havlir, MD Division of HIV/AIDS
AIDS Research and Services at SF General Hospital Diane V. Havlir, MD Division of HIV/AIDS
Clinical Studies of Interactions Between HIV and Malaria Diane V. Havlir, MD Division of HIV/AIDS
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) Diane V. Havlir, MD Division of HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trials Group (ACTG) TTSG Services Diane V. Havlir, MD Division of HIV/AIDS
Adult AIDS Clinical Trials Unit (AACTU) Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane V. Havlir, MD Division of HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane V. Havlir, MD Division of HIV/AIDS
Therapeutic Strategies for HIV Disease Diane V. Havlir, MD Division of HIV/AIDS
Training in HIV Translational Research Diane V. Havlir, MD Division of HIV/AIDS
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Diane V. Havlir, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Heals Endowment Fund at the East Bay Community Foundation Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) Diane V. Havlir, MD Division of HIV/AIDS
Getting to Zero Coordinator/ SFPHF Diane V. Havlir, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane V. Havlir, MD Division of HIV/AIDS
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Diane V. Havlir, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Training in HIV Translational Research Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trials Group (ACTG) Community Health Promoter Diane V. Havlir, MD Division of HIV/AIDS
Therapeutic Strategies for HIV Disease Diane V. Havlir, MD Division of HIV/AIDS
Determinants of HIV Transmission Frederick M. Hecht, MD Division of HIV/AIDS
Comparison of Assays to Measure Viral Reservoirs in HIV Eradication Frederick M. Hecht, MD Division of HIV/AIDS
Understanding the role of treatment timing cells and human genetics to explain why HIV drugs do not cure HIV Frederick M. Hecht, MD Division of HIV/AIDS, AIDS Research Institute
Characterization of Persistent HIV Viremia Frederick M. Hecht, MD Division of HIV/AIDS
Options Project Frederick M. Hecht, MD Division of HIV/AIDS
HIV Exposure in a Sample of HESN Men Having Sex with Men Frederick M. Hecht, MD Division of HIV/AIDS
The Biology of HIV Transmission Frederick M. Hecht, MD Division of HIV/AIDS
The Biologic Determinants of HIV Transmission / HIV Applied Research Frederick M. Hecht, MD Division of HIV/AIDS
T Regulatory Cells in HIV Infection Frederick M. Hecht, MD Division of HIV/AIDS
FIND Xpert MTB assay collaboration at Mulago Hospital Laurence Huang, MD Division of HIV/AIDS
Molecular Epidemiology of Human P. Carinii Pneumonia Laurence Huang, MD Division of HIV/AIDS
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV Laurence Huang, MD Division of HIV/AIDS
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD Division of HIV/AIDS
Patient-Oriented Research and Mentoring in Pneumocystis Laurence Huang, MD Division of HIV/AIDS
Specimens Related to the MU-UCSF Research Collaboration Laurence Huang, MD Division of HIV/AIDS
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease Laurence Huang, MD Division of HIV/AIDS
PCP OPW Specimens Laurence Huang, MD Division of HIV/AIDS
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study Laurence Huang, MD Division of HIV/AIDS
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Division of HIV/AIDS
UCSF-FIND Uganda Project Laurence Huang, MD Division of HIV/AIDS
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. Laurence Huang, MD Division of HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD Division of HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Laurence Huang, MD Division of HIV/AIDS
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis Laurence Huang, MD Division of HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) Laurence Huang, MD Division of HIV/AIDS
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) Laurence Huang, MD Division of HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD Division of HIV/AIDS
Evaluate Serum-Based Assay for Pneumocystis Pneumonia Diagnosis Laurence Huang, MD Division of HIV/AIDS
HIV Pathogenesis and Immunity in Viremic Non-Progressors Peter W. Hunt, MD Division of HIV/AIDS
The Determinants of T Cell Activation in HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa Peter W. Hunt, MD Division of HIV/AIDS
Intestinal MAIT Cells in HIV Infection Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Investigating Mechanisms of HIV Persistence in the Gut Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Peter W. Hunt, MD Division of HIV/AIDS
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
HIV-Specific T-Cell Responses in Rectal Mucosa Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Mesalamine to Reduce T Cell Activation in HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Peter W. Hunt, MD Division of HIV/AIDS
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans Peter W. Hunt, MD Division of HIV/AIDS
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans Peter W. Hunt, MD Division of HIV/AIDS
HIV-Specific T-cell Responses in Rectal Mucosa Peter W. Hunt, MD Division of HIV/AIDS
Valganciclovir to Reduce T Cell Activation in HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention Prasanna Jagannathan, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Impact of Parasitemia on the Development of Cellular Immune Responses to Malaria Prasanna Jagannathan, MD Division of HIV/AIDS
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Adherence Improvement & Measurement (AIM) System Division of HIV/AIDS
HIV Emergence of Drug Resistance Division of HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne F. Luetkemeyer, MD Division of HIV/AIDS
Pfizer A4001027: Observational Phase Extension Anne F. Luetkemeyer, MD Division of HIV/AIDS
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men Anne F. Luetkemeyer, MD Division of HIV/AIDS
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne F. Luetkemeyer, MD Division of HIV/AIDS
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne F. Luetkemeyer, MD Division of HIV/AIDS
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne F. Luetkemeyer, MD Division of HIV/AIDS
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Anne F. Luetkemeyer, MD Division of HIV/AIDS
Gilead GS-US-236-0102 Anne F. Luetkemeyer, MD Division of HIV/AIDS
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV Anne F. Luetkemeyer, MD Division of HIV/AIDS
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:) Anne F. Luetkemeyer, MD Division of HIV/AIDS
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne F. Luetkemeyer, MD Division of HIV/AIDS
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne F. Luetkemeyer, MD Division of HIV/AIDS
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected Anne F. Luetkemeyer, MD Division of HIV/AIDS
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne F. Luetkemeyer, MD Division of HIV/AIDS
ViiV Healthcare A4001098 Anne F. Luetkemeyer, MD Division of HIV/AIDS
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne F. Luetkemeyer, MD Division of HIV/AIDS
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects Anne F. Luetkemeyer, MD Division of HIV/AIDS
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s Anne F. Luetkemeyer, MD Division of HIV/AIDS
GS_US_342-1139: Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Infecti Anne F. Luetkemeyer, MD Division of HIV/AIDS
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255 Anne F. Luetkemeyer, MD Division of HIV/AIDS
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne F. Luetkemeyer, MD Division of HIV/AIDS
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay Anne F. Luetkemeyer, MD Division of HIV/AIDS
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1 Anne F. Luetkemeyer, MD Division of HIV/AIDS
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C Anne F. Luetkemeyer, MD Division of HIV/AIDS
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) Anne F. Luetkemeyer, MD Division of HIV/AIDS
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
The effects of alcohol on acute HIV associated neurocognitive disorders Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Host Factors Influencing HIV Viral Load and Infectivity in Semen Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
HIV Incidence Testing using Multiple Biological Specimens Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Data Collected through the IAVI Early Infection Cohort Study Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Targeting Acute HIV Christopher D. Pilcher, MD Division of HIV/AIDS
Development of Specimen Repository and Evaluation of Assays for Identification of Recent HIV Infection Christopher D. Pilcher, MD Division of HIV/AIDS
HIV Incidence Testing in Hair Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
HIV RNA and/or Antibody Confirmed Positive Plasma Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay Christopher D. Pilcher, MD Division of HIV/AIDS
Wave 80 Fingerstick Pilot Study Christopher D. Pilcher, MD Division of HIV/AIDS
A Pilot of Intervention to Promote Acute HIV Testing by Ambulatory Care Providers Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Discovery of Oxaboroles as New Antimalarial Agents Philip J. Rosenthal, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV Sheri D. Weiser, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Food Insecurity: A Key Structural Barrier to HIV/AIDS Care Sheri D. Weiser, MD Division of HIV/AIDS
Changing Health through Food Support (CHeFS) Pilot Study (POH) Sheri D. Weiser, MD Division of HIV/AIDS
Exploring the Impact of Urban Gardens on Food Insecurity and Health of Low Income Californians: A Community Research Partnership Sheri D. Weiser, MD Division of HIV/AIDS
Exploring the Bidirectional Relationship between Food Security and HIV Treatment Outcomes in a Rural Ugandan Cohort Sheri D. Weiser, MD Division of HIV/AIDS
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri D. Weiser, MD Division of HIV/AIDS
Pathways contributing to racial disparities among HIV clinic cohort patients Sheri D. Weiser, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, Prevention Science (formerly the Center for AIDS Prevention Studies or CAPS)
Women's Interagency HIV (WIHS-V) S. Weiser Sheri D. Weiser, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri D. Weiser, MD Division of HIV/AIDS
Gender Effects on HIV Biology Ruth M. Greenblatt, MD Division of HIV/AIDS
Women's Specialty Program Infrastructure Support Contract Ruth M. Greenblatt, MD Division of HIV/AIDS
WIHS Treatment Exposure and Viral Rebound Study / AIDS Research Ruth M. Greenblatt, MD Division of HIV/AIDS
Primary Care Services- Non Severe Need - Ward 86 Division of HIV/AIDS, AIDS Research Institute
Hepatitis C Co-infection Clinic: A to T (Acute to Transplant) Division of HIV/AIDS
Positive Health Access to Service and Treatment (PHAST) Division of HIV/AIDS
Ward 86 Outpatient Services/Perinatal Services Division of HIV/AIDS
Ward 86 Outpatient Services/Perinatal Services Division of HIV/AIDS
The Use of Nelfinavir During Acute or Early HIV Infection - Safety, Tolerability, Durablilty and Resistance Division of HIV/AIDS, AIDS Research Institute
She's Living Positive Health Fair Division of HIV/AIDS
African American Center of Excellence Division of HIV/AIDS
Treatment of Acute Hepatitis C Virus in HIV Co-Infection Division of HIV/AIDS, AIDS Research Institute
Darpun Sachdev mentored participation in HIV Clinical Trials Division of HIV/AIDS, AIDS Research Institute
Expanded HIV Testing for Disproportionately Affected Population Division of HIV/AIDS
Positive Health Access to Service and Treatment (PHAST) Division of HIV/AIDS
Ward 86 Outpatient Services / Perinatal Services Division of HIV/AIDS
Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C Division of HIV/AIDS
CHRP for Integrating HIV and Geriatric for People Living with HIV 50 and Over Division of HIV/AIDS
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) Division of HIV/AIDS
Family Service Networks - Centers of Excellence Division of HIV/AIDS, AIDS Research Institute
Women's Center of Excellence Division of HIV/AIDS
Chronic Care HIV/AIDS Multi-Disciplinary Program (CCHAMP) Division of HIV/AIDS
Positive Health Access to Services and Treatment (PHAST) Division of HIV/AIDS
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Division of HIV/AIDS, AIDS Research Institute
Outpatient Services Ward 86 Division of HIV/AIDS, AIDS Research Institute
Family Services Network - Ryan White HIV/AIDS Program Division of HIV/AIDS
Ryan White Title IV Program: Integrated Family Services Network / AIDS-related Division of HIV/AIDS, AIDS Research Institute
KAM Training Division of HIV/AIDS
Stored Blood Specimens Division of HIV/AIDS
HIV Health Services - Program Database Services Division of HIV/AIDS, AIDS Research Institute
Sexual Harm Reduction for HIV+ Gay Men (Prevention with Positives) Division of HIV/AIDS, AIDS Research Institute
Ryan White Title IV Program: Family Services Network Division of HIV/AIDS, AIDS Research Institute
Abbott Preceptorship Division of HIV/AIDS, AIDS Research Institute
Positive Health Access to Services and Treatment (PHAST) Division of HIV/AIDS
HIV Treatment Training for Clinical Setting Division of HIV/AIDS, AIDS Research Institute
HIV Clinical Scholars Fellowship Royce C. Lin, MD Division of HIV/AIDS
HIV Clinical Scholars Fellowship Royce C. Lin, MD Division of HIV/AIDS
Effects of Housing and HIV on Risk Behavior and Victimization of Indigent Women Elise Riley, PhD Division of HIV/AIDS
The Influence of Pharmacy-Based Syringe Disposal on Unsafe Syringe Discard Among Injection Drug Users in California Elise Riley, PhD Division of HIV/AIDS
HPV Epidemiology and Response to Screening (HEARTS) Elise Riley, PhD Division of HIV/AIDS
A Clinical Trial of DOT for HAART in Jailed Drug Users / AIDS Related Jacqueline P. Tulsky, MD Division of HIV/AIDS
Crossing Boundaries: Continuity of Medical Care for Incarcerated Adults Jacqueline P. Tulsky, MD Division of HIV/AIDS
Seek, Test, Treat and Retain Strategies Leveraging Mobile Health and Internet-Based Technologies Jacqueline P. Tulsky, MD Division of HIV/AIDS
Administering Buprenorphine in the San Francisco County Jail Jacqueline P. Tulsky, MD Division of HIV/AIDS
Host Genetic Predictors of IDO-induced Tryptophan Catabolism Among HIV-Infected Ugandans Maintaining Treatment-Mediated Viral Suppression Sulggi A. Lee, MD Center for AIDS Research (CFAR), Division of HIV/AIDS
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts (SILCAAT) James G. Kahn, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Behavioral, Basic, and Clinical Studies of PEP Michelle Roland, MD Division of HIV/AIDS
The Social Context of HIV Post-Exposure Prophylaxis (PEP) Michelle Roland, MD Division of HIV/AIDS
Office of the UN Special Envoy for Tuberculosis Eric Goosby, MD Global Health Sciences (GHS), Division of HIV/AIDS
Reactivation of latent HIV using recombinant galectin-9 Division of HIV/AIDS, AIDS Research Institute
Capacity Based Assistance (CBA) for High Impact HIV Prevention to Health Departments in the United States Deborah L. Cohan, MD, MPH Division of HIV/AIDS
Continuum of HIV Prevention Care Services Deborah L. Cohan, MD, MPH Division of HIV/AIDS
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients Mark A. Jacobson, MD Division of HIV/AIDS